Skip to main content
. Author manuscript; available in PMC: 2017 Oct 7.
Published in final edited form as: J Proteome Res. 2017 Sep 14;16(10):3704–3710. doi: 10.1021/acs.jproteome.7b00405

Figure 2.

Figure 2

Lower relative abundance of H4-K12acK16ac in HRD versus non-HRD tumors. (A) H4-K12acK16ac was measured by PRM in 45 HRD and 35 non-HRD tumors. (B) Quantifiable levels of H4-K12acK16ac were detected in 64 (34 HRD and 30 non-HRD) of the tumors that were analyzed by iTRAQ and PRM.